An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
Stefano Cascinu(Vita-Salute San Raffaele University), Giuseppina Catalano(Unknown), Pietro Muretto(Azienda Ospedaliera S.Maria), Vincenzo Catalano(Azienda Ospedaliero-Universitaria delle Marche), Simona Secondino(Azienda Ospedaliera Treviglio), Sandro Barni, Angelo Brenna, Maria Cecilia Rossi, Maria Pia Staccioli(Azienda Ospedaliera S.Maria), Anna Maria Baldelli(Azienda Ospedaliero-Universitaria delle Marche), Francesco Graziano(Ospedale Vincenzo Cervello)
Cited by 45
Related Papers
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|Journal of Clinical Oncology|2002|416
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
|The Lancet|2015|201
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
|Journal of Clinical Oncology|1994|200
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
|Journal of Clinical Oncology|2015|181